SeniorFull TimeEN
The Enterprise Implementation Lead – Horizon 2 is a senior Technical Operations leadership role accountable for the enterprise-wide technical implementation and validation of the Horizon 2 program. The Horizon 2 program included a patented, yield enhancing manufacturing technology that enables significantly higher immunoglobulin production from the same base amount of plasma. Operating within the Horizon 2 program organization, the role serves as the primary enterprise integrator across Tech Ops, Manufacturing, Quality, Engineering & Maintenance (E&M), and enabling capital projects, ensuring technical intent, process maturity, validation outcomes, program learnings, and regulatory-facing technical content are coherently translated into effective and sustainable execution at scale.
Horizon 2 Program Technical Accountabilities
The Enterprise Implementation Lead is accountable for the end-to-end technical delivery of the Horizon 2 program across development, process implementation, technology transfer, validation, and the creation of development and technical content required to support global regulatory filings. This includes translating development outputs into scalable, compliant manufacturing solutions and ensuring that process knowledge, control strategies, validation evidence, and regulatory-facing technical narratives are robustly established to enable successful submissions and ongoing deployment as well as new expansion across the CSL network.
Cross-Functional Collaboration, Integration & Governance
The incumbent is expected to operate with an enterprise mindset, demonstrate CSL values, uphold quality and patient safety standards, and comply with all CSL policies, procedures, and regulatory requirements. CSL Behring is an equal opportunity employer and is committed to diversity, equity, and inclusion in the workplace.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
